Huby et al.1 have offered their interpretation of our recent study2 in which we showed the importance of membrane lipid rafts in major histocompatibility complex (MHC) class II–restricted T cell activation. They propose that because the plasma membrane contains so many lipid rafts and so few specific peptide–class II complexes are required to activate T cells, it is unlikely that lipid rafts could serve to concentrate the specific class II–peptide complexes that are necessary for T cell activation. However, it is not known yet how many lipid rafts are on the surface of antigen presenting cells (APCs); how many class II molecules are present in each lipid raft; whether antigen-loading onto newly synthesized class II molecules is truly random; or whether the specific peptide complexes required to activate antigen-specific T cells are randomly distributed on the plasma membrane.

Huby et al. propose that aggregation of class II with lipid rafts serves to increase the local concentration of class II–peptide complexes only if specific class II–peptide complexes are recruited to and associate with a restricted pool of membrane rafts at (presumably) the immunological synapse. This model predicts that disrupting raft integrity on APCs before chemical fixation would not alter the efficiency of antigen presentation to T cells. However, our paper showed that raft disruption inhibits T cell activation by fixed APCs—a result that does not fit into their model.

Using paraformaldehyde-fixed APCs at low doses of protein antigen, we show the importance of lipid raft microdomains in antigen presentation. As mentioned, the effect of raft-disrupting drugs on live cells is reversible and these drugs can directly inhibit T cell activation. These considerations necessitated chemical fixation of the APCs after the addition of raft-disrupting drugs, thereby preventing reassembly of raft-protein complexes, and removal of these drugs before analysis of T cell activation. Of course proteins are not fixed on the plasma membrane of APCs in vivo and they often reorganize on the plasma membrane after ligation. By analogy with the well documented ability of lipid rafts to reorganize on the plasma membrane of T cells, we propose that engagement of specific class II molecules with the TCR on antigen-specific T cells leads to the aggregation of the rafts containing these complexes at the immunological synapse. As there are presumably “irrelevant” and “relevant” class II–peptide complexes in the same lipid raft, one might be able to visualize this directly.

On APCs, a significant fraction of surface class II molecules constitutively resides in lipid raft microdomains. Huby et al. originally proposed that class II association with lipid rafts only occurred after ligation of class II molecules with antibodies or, presumably, TCR engagement3. It is unlikely that the constitutive association of class II molecules with lipid rafts is a biological accident and therefore not physiologically relevant. In addition to a potential role for the concentration of lipid rafts containing class II–peptide complexes after engagement with the TCR, we propose that the “pre-packaging” of class II in lipid raft microdomains might serve to facilitate even further the concentration effects necessary for T cell activation. We look forward to rigorously testing and revising this model.

See “Rafts for antigen presentation?“ by Russell Huby and the Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation by Howard A. Anderson.